Searching for Surrogates: The Effort to Speed Up Drug Trials

Identifying surrogate endpoints for use in clinical trials that strongly predict clinical outcomes such as improved survival and quality of life is challenging.

Related Keywords

Maryland ,United States ,National Institutes Of Health ,Milan ,Lombardia ,Italy ,Oregon ,Netherlands ,France ,Gaithersburg ,San Francisco ,California ,Groningen ,French ,Fabio Conforti ,Vincent Planche ,Fady Ghali ,Karin Hoelzer ,Ginny Beakes ,Carol Taylor Burds ,Amaru Kishan ,Richard Pazdur ,Hiddol Heerspink ,Anushka Walia ,Los Angeles ,Emersony Chen ,Juliaa Beaver ,University Of California ,Drug Administration ,Pilot Meeting Program ,European Institute Of Oncology ,International Classification Of Disease ,European Renal Association ,University Of Washington School Medicine ,Oncology Center ,Amgen Inc ,University Medical Center Groningen ,Oregon Health Science University In Portland ,Stroke Biomarker Program ,Rare Diseases Information Center ,Nicolas Villain ,Washington School ,European Urology Open ,European Institute ,Nature Medicine ,Program Director ,Translational Research ,National Institute ,Neurological Disorders ,Regulatory Affairs ,National Organization ,Rare Disorders ,International Classification ,Orphan Drug Act ,National Institutes ,Rare Disease Endpoint Advancement ,Therapeutic Innovation ,Regulatory Science ,New England Journal ,Oregon Health ,Science University ,Urol Open ,Innov Regul ,